Literature DB >> 18381114

Ovarian cancer.

Nishan Chobanian1, Charles S Dietrich.   

Abstract

Ovarian cancer ranks fifth in cancer deaths among women and causes more deaths than any other gynecologic malignancy. It is estimated that 22,430 new cases will be diagnosed and 15,280 deaths will be attributed to ovarian cancer in the United States in 2007. Despite initial responses to surgery and chemotherapy in up to 80% of cases, more than 75% of affected women ultimately die from complications of disease progression.

Entities:  

Mesh：

Year:  2008        PMID： 18381114     DOI： 10.1016/j.suc.2007.12.002

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  23 in total

1.  Expression of Sox2 in human ovarian epithelial carcinoma.

Authors:  Feng Ye; Yanli Li; Ying Hu; Caiyun Zhou; Yuting Hu; Huaizeng Chen
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-27       Impact factor: 4.553

2.  The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21.

Authors:  Deok-Soo Son; Andrew J Wilson; Angelika K Parl; Dineo Khabele
Journal:  Cancer Biol Ther       Date:  2010-06-25       Impact factor: 4.742

3.  HtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation.

Authors:  Xiaoping He; Ashwani Khurana; Jacie L Maguire; Jeremy Chien; Viji Shridhar
Journal:  Int J Cancer       Date:  2011-04-25       Impact factor: 7.396

4.  Grb7 gene amplification and protein expression by FISH and IHC in ovarian cancer.

Authors:  Manman Zeng; Zhu Yang; Xiaoyu Hu; Yi Liu; Xiaotao Yang; Hailong Ran; Yanan Li; Xu Li; Qiubo Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 5.  Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.

Authors:  Xiao-Mei Zhou; Hai Zhang; Xia Han
Journal:  Tumour Biol       Date:  2014-08-29

6.  TRA-1-60+, SSEA-4+, Oct4A+, Nanog+ Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Ovaries.

Authors:  Marek Malecki; Mark Anderson; Michael Beauchaine; Songwon Seo; Xenia Tombokan; Raf Malecki
Journal:  J Stem Cell Res Ther       Date:  2012-11-18

7.  STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells.

Authors:  Yanhui Ma; Xiaolei Zhang; Xiaoxuan Xu; Liang Shen; Yao Yao; Ziyan Yang; Peishu Liu
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

8.  Primary hepatic embryonal sarcoma masquerading as metastatic ovarian cancer.

Authors:  Peter Kullar; Christopher Stonard; Neville Jamieson; Emmanuel Huguet; Raaj Praseedom; Asif Jah
Journal:  World J Surg Oncol       Date:  2009-06-23       Impact factor: 2.754

9.  Fluid-flow induced wall shear stress and epithelial ovarian cancer peritoneal spreading.

Authors:  Liron Avraham-Chakim; David Elad; Uri Zaretsky; Yoel Kloog; Ariel Jaffa; Dan Grisaru
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

10.  Inhibitory effect of tumor suppressor p53 on proinflammatory chemokine expression in ovarian cancer cells by reducing proteasomal degradation of IκB.

Authors:  Deok-Soo Son; Syder M Kabir; Yuan-Lin Dong; Eunsook Lee; Samuel E Adunyah
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.